In a double-blind, randomized, and crossover design; 12 Division III male, football players (18.8 ± 1.2 yrs; 180 ± 12 cm; 89.3 ± 11 kg; 13.6 ± 4.9% BF) completed one baseline session and two subsequent testing sessions to determine the efficacy of acute ingestion of a MIPS. The initial baseline session consisted of body composition assessment and familiarization with the jump mat and non-motorized force treadmill. In testing Session 1, participants ingested either 1 serving of a commercially available MIPS (SUP) that contained 4g of carbohydrates, 2g of creatine hydrochloride, 3g of beta-alanine, 1.5g of betaine, 1g of taurine, 600mg of N-acetyl L-Cysteine, 150mg of Alpha-Glyceryl Phoshporyl Choline, 6g of citruline malate, 500mg of beet extract, 6g of BCAA's, 1.5g of L-tyrosine, 300mg of caffeine anhydrous, 50mcg of huperzine A and 5mg of BioPerine; or a placebo (PLA). Following a post-consumption 30-minute waiting period, participants completed a warm-up of 10 body weight exercises. Next, they completed a counter-movement vertical jump (CMVJ) test on a jump mat (Just Jump System, Probotics, AL, USA), which consisted of three attempts with the highest CMVJ being recorded for analysis and converted to power (W) using previously described methods . Following the CMVJ, participants completed a 25-second maximal effort sprint test on a non-motorized force treadmill with the resistance set at 18% of their bodyweight. Session 2 followed a week later in which participants repeated the testing protocol under the opposite treatment condition (SUP or PLA).